Experience with a simplified feeding jejunostomy technique for enteral nutrition following major visceral operations by Minarich, Michael J. & Schwarz, Roderich E.
© Translational Gastroenterology and Hepatology. All rights reserved. Transl Gastroenterol Hepatol 2018;3:44tgh.amegroups.com
Original Article
Experience with a simplified feeding jejunostomy technique for 
enteral nutrition following major visceral operations
Michael J. Minarich1, Roderich E. Schwarz1,2
1Goshen Center for Cancer Care, Goshen, IN, USA; 2Department of Surgery, Indiana University School of Medicine, South Bend, IN, USA
Contributions: (I) Conception and design: All authors; (II) Administrative support: RE Schwarz; (III) Provision of study materials or patients: RE 
Schwarz; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: RE Schwarz; (VI) Manuscript writing: All authors; 
(VII) Final approval of manuscript: All authors.
Correspondence to: Roderich E. Schwarz, MD, FACS. Goshen Center for Cancer Care, 200 High Park Avenue, Goshen, IN 46526, USA.  
Email: reschwarz@aol.com.
Background: Background: Perioperative nutrition support has been shown to impact on outcomes for 
patients with gastrointestinal cancer. Postoperative benefits of feeding tubes must be weighed against 
morbidity related to placement and use. A simplified jejunostomy tube technique was evaluated for outcomes.
Methods: A 16-Fr rubber tube is secured at the jejunal entry site without Witzel tunnel, followed 
by a continuous, circumferential and alternating suture between jejunal wall and parietal peritoneum. 
Prospectively collected data were analyzed.
Results: The technique was performed in 343 of 803 major hepatopancreatobiliary and upper 
gastrointestinal (GI) resections (43%). Of these patients (male =57%, median age: 65.8 years, range, 
24.0–98.0 years), 89% had a cancer diagnosis. The procedures included pancreatectomy (n=189, 55%), 
gastrectomy (n=109, 32%), esophagectomy (n=19, 6%) and others (n=26, 7%). The operative intent was 
curative in 78%, palliative in 10%, or combined in 12% of patients. Postoperative morbidity rate was 40%, 
with 19 lethal events (5.5%), and a median length of stay of 10 days (range, 4–111 days). Tube feeds were 
administered in 139 patients (41%), and in 17% continued beyond discharge. Use of the feeding tube was 
linked to treatment interval, length of stay, major complication grade (all at P<0.0001), metastatic stage 
(P=0.0007) and noncurative intent (P=0.001). Tube feeds beyond discharge were associated with time interval 
(P<0.0001), length of stay (P=0.0006) and noncurative intent (P=0.014). Tube-specific events in 38 patients 
(11%) were all minor, without any intraabdominal leak, infection or obstruction.  
Conclusions: The technique described is safe and expedient, and the overall tube-related morbidity is low. 
This procedure can be recommended in cases at risk for major morbidity and nutrition support needs.
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Introduction
Nutritional deficits, commonly encountered in patients with 
gastrointestinal cancers, increase the risk for postoperative 
morbidity and are among those parameters that can be 
manipulated to achieve superior postoperative outcomes in 
complex surgical patients (1). The potential value of nutritional 
repletion in patients undergoing major operative procedures in 
order to minimize operative complications has been evaluated 
in numerous studies. Generally, a value of enteral nutrition 
support in this setting has been primarily demonstrated through 
preoperative or perioperative nutrition efforts where feasible 
(2,3), while there is less evidence for benefits from routine 
postoperative nutrition support (4-7). However, postoperative 
enteral nutrition may still be valuable in settings of major 
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complications, benefit earlier discharge, lead to shortened 
recovery or improve the ability to undergo postoperative therapy 
(8,9). Any possible postoperative benefits of feeding tubes must 
be weighed against the morbidity related to their placement and 
subsequent use, both of which depend on several other factors. 
For instance, the literature is unclear on whether placement of 
prophylactic feeding tubes at the time of resection by itself does 
or does not contribute to increased postoperative morbidity 
(10,11). The decision to place a feeding tube at the time of 
major upper gastrointestinal or hepato-pancreato-biliary 
resection should thus be guided by the nutritional risk of 
the patient, the likelihood of major postoperative morbidity 
with nutritional support needs, the safety and utility of the 
feeding access device chosen, the availability of alternative, 
endoscopically placed postoperative feeding access if needed 
and the possible utility or value of parenteral nutrition 
support. A previously described simplified technique 
of jejunostomy tube (JT) placement that is thought to 
be characterized by technical ease, minimal additional 
operating time, maximal safety and minimal device-related 
morbidity is now evaluated for circumstances of clinical use 
and related outcomes (12).
Methods
Feeding jejunostomy technique
The technique was originally described in 2002, but a few 
minor amendments have been instituted since that time (12). 
Briefly, the key steps can be summarized as follows:
(I) A 16-Fr red rubber catheter is inserted through 
the abdominal wall in a lateral location in order 
to minimize the risk for any possible small bowel 
volvulus around the tube;
(II) Tunneling of the catheter through the abdominal 
wall musculature is directed in an oblique direction 
towards the pelvis to lengthen the ensuing tunnel 
within the abdominal wall soft tissue, and to 
facilitate any necessary tube replacement;
(III) A triangular seromuscular purse-string suture using 
3-0 Vicryl or PDS on the antimesenteric jejunal 
border is placed approximately 10 centimeters 
distal to the lowest jejunal anastomosis (Figure 1A). 
The tip of the catheter is cut off to avoid any 
premature occlusion of side hole openings and to 
maximize the effect of flushes;
(IV) The catheter is inserted into the jejunal lumen, and 
the purse-string suture is tied (Figure 1B). Injection 
of saline solution through the catheter eases its 
advancement into the bowel;
(V) A 3-0 PDS purse-string suture secures the 
seromuscular jejunal components to the parietal 
peritoneum; only four stitches are placed on each 
side in a continuous, alternating, circumferential 
suture line (Figure 1C,D). Exposure is optimized by 
starting in the caudad suture portion, advancing to 
the posterior area, and delaying suture tightening 
until all four stitches are placed (Figure 1E);
(VI) The tube is sutured to the outside skin with 2-0 silk 
in two locations, flushed to ascertain patency, and 
capped (Figure 1F).
The original description also included approximation 
of a segment of small bowel the lateral abdominal wall in 
the left paracolic gutter, intended as a preventive measure 
against possible small bowel volvulus. This step has since 
been eliminated, with no resulting adverse events noted.
Clinical data analysis
Institutional Review Board approval was obtained for 
the prospective collection of data related to feeding JT 
placement. All clinical information was derived from a 
consecutive patient series of major abdominal operative 
procedures with curative or palliative intent by a single 
attending surgeon in an academic surgical oncology 
practice setting. Clinicopathological data for all patients 
had been prospectively collected. The series includes 343 
consecutive patients collected over a 15-year period. The 
analysis focused on variables associated with JT placement 
and those related to feeding tube use postoperatively or 
after discharge from the hospital, in addition to device-
related events and parameters affecting length of stay (LOS). 
Postoperative complications were graded according to the 
5-grade scale proposed by Clavien and colleagues (13). 
In cases of multiple complications, that with the greatest 
severity determined the final grade. Postoperative lethal 
events were defined as those occurring during the in-
hospital stay or within 30 days after the procedure. Patients 
experiencing lethal outcomes during their postoperative 
admission were excluded from the LOS calculation.
Continuous data between groups were compared via 
Student’s t-test, or Mann-Whitney analysis, based on the 
original data distribution. Chi square contingency testing 
was used for categorical data. Multiple logistic regression for 
feeding tube use was applied in a stepwise backward model, 
only entering covariates that met univariate significance. 
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All calculations were performed using StatView software 
for Macintosh, version 5.0.1 (SAS Institute Inc., Cary, 
NC, USA). Statistical significance of group differences was 
assumed at a P value of <0.05. 
Results
Patient demographics, clinical characteristics and early 
outcomes
The described feeding tube placement technique was 
performed in 343 of 803 major hepatopancreatobiliary 
and upper gastrointestinal (GI) resections (43%). It was a 
standard recommendation for elective procedures involving 
resection of the esophagus, total or near-total stomach and 
upper or mid-duodenum, or was used widely for palliation 
of malignant bowel obstruction; it was utilized selectively 
for partial gastrectomies or other midgut resections. Of the 
343 patients receiving a JT, 196 were male (57%) and 147 
were female (43%), with a median age of 65.8 years (range: 
24.0–98.0 years). Diagnoses included disorders of the 
pancreas or periampullary tissues (n=184, 54%), stomach 
(n=114, 33%), esophagus (n=23, 7%) and duodenum (n=22, 
6%); a cancer diagnosis was confirmed in 306 (89%). 
Final pathologic cancer stage grouping yielded stages 
0 (n=8, 3%), I (n=58, 19%), II (n=118, 38%), III (n=71, 
23%) and IV (n=51, 17%). Operative procedures included 
pancreatoduodenectomy (PD, n=189, 55%), gastrectomy 
(n=109, 32%), esophagectomy (n=19, 6%) and others (n=26, 
7%); the latter represented other intestinal resections (n=4, 
1%), bypass procedures (n=15, 4%), and procedures without 
intestinal anastomosis (n=7, 2%). The operative intent was 
curative in 78%, palliative in 10%, or combined in 12% of 
patients. 
The postoperative morbidity rate was 40%, with 204 
patients remaining complication-free (60%), 70 developing 
a minor complication (grade 1 or 2, 20%) and 69 
experiencing major morbidity (grades 3–5, 20%) including 
19 lethal events (5.5%), 
The median LOS of was 10 days (range, 4–111 days) 
and differed based on postoperative morbidity, with group 
medians of 9 days without, 11.5 days with minor and 20 
days with major complications (Figure 2). 
A B C
D E F
Figure 1 Technique of tunnel-free jejunostomy feeding tube placement. (A) Enterotomy with 3-point purse-string suture; (B) tied purse-
string suture after 16-Fr catheter insertion; (C) 3-0 PDS bowel-to-parietal-peritoneum suture; (D) circumferential alternating continuous 
suturing; (E) tied circumferential 3-0 PDS suture; (F) external dual fixation of jejunostomy tube. 
© Translational Gastroenterology and Hepatology. All rights reserved. Transl Gastroenterol Hepatol 2018;3:44tgh.amegroups.com
Page 4 of 8 Translational Gastroenterology and Hepatology, 2018
Feeding tube utilization
In the early part of this experience, tube feeds (TF) were 
routinely initiated on postoperative day 3, affecting 89 
patients within the total cohort (26%). This practice 
was altered over time, and tube feeds were subsequently 
no longer routinely applied but reserved for nutrition 
support during major postoperative morbidity or in 
situations of severe preoperative nutrition compromise. 
Overall, tube feeds were administered postoperatively in 
139 patients (41%) but only continued in 17% at time 
of discharge. With a selective tube feeding policy during 
the second and third study interval, 50 of 254 patients 
received postoperative enteral feeding support (20%), 
with feeds continued after discharge in 6%. Utilization 
of the feeding tube was linked to cancer stage group, 
noncurative treatment intent, treatment time interval, 
complication grade and LOS (Table 1), but not to age, 
gender, weight loss history, preoperative albumin, 
ASA grade, diagnostic group, history of preoperative 
chemotherapy or chemoradiation, type of resection 
performed or margin status. On multivariate analysis, 
LOS, complication grade and noncurative intent emerged 
as the only independent variables linked to tube feeding 
use (Table 2). Tube feeds maintained beyond discharge 
were ultimately only associated with time interval 
(P<0.0001), LOS (P=0.0006) and noncurative intent 
(P=0.014) (Table 2). The impact of diagnosis, cancer 
stage group, operative procedure (9% after PD, between 
22% and 27% after all others) and the initial strategy for 
routine use of TF, all significant univariate factors, lost a 
significant association in the multivariate setting. There 
was no association between TF after discharge and age, 
gender, cancer diagnosis, margin status or postoperative 
complications in either analysis.
Feeding tube-related events
Tube-related events in 38 patients (11%) included occlusion 
(n=14), drainage around the tube (n=17), pain (n=3), and 
accidental removal (n=4) but no intraabdominal leaks, 
infections or intestinal obstructions. None of the tube-
specific morbidity events reached a severity grade of 
greater than 2, in fact all but two were rated as grade 1. 
No intravenous medications were required for device-
related infections or symptoms. Patients with prolonged 
feeding tube needs, or those with significant drainage of 
succus around the initial tube underwent placement of a 
balloon catheter for intraluminal tract control. In three 
patients, a subsequent tube exchange for long-term access 
was performed in an interventional radiology procedure. 
Although 19 patients (5%) required suture placement at 
the cutaneous JT entry site after removal of the tube rather 
than the occluding adhesive paper strips otherwise used, all 
sites healed well without need for additional interventions. 
JT events were observed in 21 of 56 patients with tube 
feeds beyond discharge (38%), compared to 6% of patients 
who did not receive tube feeds at discharge, indicating a 
propensity to develop feeding tube related issues during a 
longer course of tube feedings administered (P<0.0001).
Discussion
The role for postoperative nutrition support in patients 
undergoing major visceral resections for gastrointestinal 
cancer remains controversial. Several studies have shown 
advantages to enteral over parenteral nutrition access, and 
have demonstrated that the use of intestinal postoperative 
feeds is feasible and safe (5,14). Aside from the potential 
for reduced postoperative complication rates and LOS, 
enteral nutrition supplements were found to be beneficial 
regarding adjuvant cancer therapy delivery as they allowed 
for a greater rate of successful treatment completion (8). 
However, a randomized control trial in 195 patients 
failed to show clear evidence for a postoperative enteral 
nutrition benefit (15). Interestingly, a trend for lower 
infectious morbidity in patients receiving postoperative 
tube feeds was offset in this trial by a greater rate of 
intestinal complications such as partial small bowel 
obstruction and prolonged ileus. Other trials have indicated 
improved outcomes when nutrition support was delivered 
perioperatively or preoperatively compared to just in the 
postoperative period (2,3,16). Attempts to allow for early 
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Table 1 Postoperative feeding tube use, by demographic and clinicopathologic characteristics
Variable Subgroup Patient n (total cohort: n=343) Feeding tube use (n=139, 41%), n [%] P value
Gender Male 196 86 [44] NS
Female 147 53 [36]
Age (years) 24–59 120 48 [40] NS
60–69 94 33 [35]
70–98 129 58 [45]
Diagnosis 
group
Esophagus 23 12 [52] 0.06
Stomach 114 54 [47]
Duodenum 22 5 [23]
Pancreas/periampullary 184 68 [37]
Cancer 
diagnosis
Cancer 306 126 [41] NS
No cancer 37 13 [35]
Cancer stage 
group
Locoregional (0–III) 255 93 [36] 0.0007
Metastatic (IV) 51 33 [65]
No cancer 37 13 [35]
Treatment 
intent
Curative 304 114 [38] 0.0014
Noncurative 39 25 [64]
Procedure Esophagectomy 19 9 [47] NS
Gastrectomy 109 50 [46]
Pancreatoduodenectomy 189 65 [34]
Other resection/bypass 26 15 [58]
Treatment 
interval
Early third 89 89 [100] <0.0001
Mid third 138 23 [17]
Late third 116 27 [23]
Postoperative 
morbidity
None 204 66 [32] <0.0001
Minor 70 23 [33]
Major 69 50 [72]
Length of 
stay
a
<14 days 247 69 [28] <0.0001
14 days or longer 77 60 [78]
a
, inpatient lethal events are excluded. NS, not significant.
postoperative oral nutrition have so far led to mixed results 
and have not eliminated the potential role for enteral 
nutrition support (17,18). Utilization of postoperative tube 
feeds in the current series has also changed over time. The 
initial practice of routine postoperative feeds has been 
disbanded in favor of selective feedings in cases of major 
complications or delayed oral diet tolerance. In addition, 
patient scheduled for high-risk procedures are encouraged 
to use preoperative oral immunonutrition supplements as 
supported by randomized trial data (3).
Irrespective of the actual benefit of enteral nutrition 
support in the postoperative setting, feeding tubes can still 
be reasonably placed as prophylactic measures at the time 
of major upper gastrointestinal and pancreatic resections 
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Table 2 Multivariate analyses for feeding tube use
Analysis Covariate Univariate P value Multivariate P value
Postoperative tube feeds Length of stay <0.0001 <0.0001
Complication grade <0.0001 0.0011
Noncurative intent 0.0014 0.0227
Tube feeding strategy <0.0001 NS
Time interval <0.0001 NS
Cancer stage group 0.0007 NS
Tube feeds at discharge Time interval <0.0001 <0.0001
Length of stay <0.0001 0.0006
Noncurative intent <0.0001 0.014
Tube feeding strategy <0.0001 NS
Operative procedure 0.0019 NS
Diagnosis 0.0022 NS
Cancer stage group 0.0013 NS
(19-21). Although in some centers endoscopic percutaneous 
JTs can be placed postoperatively upon demand with a 
success rate as high as 86% (22), this special expertise is still 
of limited availability in those acutely ill patients suffering 
from severe postoperative complications, or challenging 
to implement in those individuals who fail to tolerate 
oral diets within 1 week or more after the operation. 
Parenteral nutrition support may be considered in these 
settings, but carries some clear disadvantages related to 
hepatic tolerance, infectious complications and costs (7,14). 
Most patients undergoing resective or palliative bypass 
procedures for cancer have to be considered at increased 
nutritional risk that can be linked to greater postoperative 
complication hazards. A reliable and validated nutritional 
assessment tool to predict postoperative nutrition support 
needs for this patient cohort does not yet exist, although 
a screening approach has been proposed (23) and some 
nutritional indices appear to fare better than others (24-26); this 
method could support the strategy to selectively provide 
nutrition access at the time of operation in those individuals 
considered at potential risk. Since in the current series 
postoperative complications and increased LOS were the 
dominant determinants for postoperative feeding tube use, 
validated predictors of postoperative morbidity such as 
the NSQIP or POSSUM scores could also be considered 
potential guides for selective operative placement of 
jejunostomies. However, it is still mandatory that ease of 
tube placement and overall safety can justify this maneuver.
The described technique has been used for over a 
decade now with good success in terms of absence of major 
morbidity, and has provided reliable access for enteral 
nutrition support whenever required in the postoperative 
period. Modification to the original technique have been 
minor, and the procedure remains technically easy and 
swift (12). Outcomes comparison to other published JT 
placement techniques provide sufficient evidence to consider 
this a valid or superior JT option due to its absence of any 
major tube-related complication as described by others at a 
low but appreciable frequency (5,27-34). It is acknowledged 
that some published reports on specific techniques or large 
single-institution series carry an inherent bias towards 
positive outcomes that does not guarantee equal results in 
other settings (32). For instance, morbidity rates related 
to various feeding tube techniques as reported in several 
trials for postoperative enteral feeds range from 10% to 
35% (27,33,35), but may be as high as 50% or above (6). 
We believe that the technique presented here would lend 
itself to widespread use with good outcomes due to its 
simplicity and apparent safety. We have not observed a need 
for routine gastric decompression during JT use as reported 
by others (19); at least for pancreatectomy, postoperative 
nasogastric tube (NGT) reinsertion rates of around 
20% were independent from early postoperative NGT 
decompression or subsequent JT use for enteral feeding (36). 
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There also has not been a need to perform an interventional 
procedure to place a larger bore tube in cases of prolonged 
tube requirements such as after needle-catheter JTs (31). In 
fact, all tube exchanges into an equal-size, 16-Fr balloon-
tipped catheter have been uncomplicated, and there is 
no longer any perceived need to obtain routine contrast 
radiographs to verify the new tube position as long as the 
tube is easily flushed and succus is obtained via aspiration.
It is concluded that the feeding JT technique described 
is a safe and reliable procedure with minimal additional 
operative time requirements. The technique is also 
suitable for laparoscopic procedures, blocked tubes are 
easily replaced without guidewire or imaging support, the 
potential for long-term access is given and tube removal 
is generally uncomplicated. A necessity for successful JT 
placement with this approach, however, is sufficient mobility 
of the proximal jejunum to reach to the abdominal wall. 
Avoidance of a Witzel tunnel is likely related to the fact that 
no intestinal obstructive events were observed. The overall 
tube-related morbidity is limited and of low severity, with 
no cases of obstruction, volvulus or intraabdominal leakage 
and therefore no need for any reoperation or interventional 
drainage. Although the majority of patients in this series 
did not require prolonged postoperative tube feeds, the 
author continues to perform this procedure after major 
upper GI resections to provide prophylactic feeding access 
to patients in case of significant postoperative morbidity 
or delayed gastrointestinal functional recovery with 
resulting enteral nutrition support needs. The technique 
can be recommended to surgeons who consider providing 
intraoperative enteral feeding access for the moderate to 
high nutritional risk patient.
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